For the full year, the company billed 41,586 tissue-based units and 45,700 liquid-based units, representing growth of 31% and 28%, respectively. Cash balance at year-end was $46.8M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
